Dr. Stephanie Blank, MD
Claim this profileMount Sinai Hospital
Studies Endometrial Adenocarcinoma
Studies Endometrial Cancer
5 reported clinical trials
10 drugs studied
Area of expertise
1Endometrial Adenocarcinoma
Stage III
Stage IV
HER2 positive
2Endometrial Cancer
Stage III
Stage IV
HER2 positive
Affiliated Hospitals
Clinical Trials Stephanie Blank, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting2 awards Phase 3
More about Stephanie Blank, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Stephanie Blank, MD has experience with
- Carboplatin
- Paclitaxel
- ACR-368
- Gemcitabine
- Bilateral Salpingectomy
- Bilateral Salpingectomy With Oophorectomy
Breakdown of trials Stephanie Blank, MD has run
Endometrial Adenocarcinoma
Endometrial Cancer
Uterine Cancer
Ovarian Cancer
Fallopian Tube Carcinosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie Blank, MD specialize in?
Stephanie Blank, MD focuses on Endometrial Adenocarcinoma and Endometrial Cancer. In particular, much of their work with Endometrial Adenocarcinoma has involved Stage III patients, or patients who are Stage IV.
Is Stephanie Blank, MD currently recruiting for clinical trials?
Yes, Stephanie Blank, MD is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Stephanie Blank, MD has studied deeply?
Yes, Stephanie Blank, MD has studied treatments such as Carboplatin, Paclitaxel, ACR-368.
What is the best way to schedule an appointment with Stephanie Blank, MD?
Apply for one of the trials that Stephanie Blank, MD is conducting.
What is the office address of Stephanie Blank, MD?
The office of Stephanie Blank, MD is located at: Mount Sinai Hospital, New York, New York 10011 United States. This is the address for their practice at the Mount Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.